Impaired mutagenic activities of MPDP+ (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP+ (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 15, 2007, Pages 5150-5157

  Ulanowska, Katarzyna ^a   Piosik, Jacek ^a   Gwizdek Wiśniewska, Anna ^a   Wegrzyn, Grzegorz ^a,b  

^a UNIVERSITY OF GDA SK   (Poland)

^b INSTITUTE OF OCEANOLOGY   (Poland)

Author keywords

Methylxanthines; MPDP+ (1 methyl 4 phenyl 2,3 dihydropyridinium); MPP+ (1 methyl 4 phenylpyridinium); Mutagenicity; Parkinson's disease; Stacking complexes

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2,3 DIHYDRO 1 METHYL 4 PHENYLPYRIDINIUM; CAFFEINE; METHYLXANTHINE; NEUROTOXIN; PENTOXIFYLLINE;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN;

1-METHYL-4-PHENYLPYRIDINIUM; CAFFEINE; CALORIMETRY; DRUG INTERACTIONS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MUTAGENS; PENTOXIFYLLINE; PYRIDINIUM COMPOUNDS; SPECTROPHOTOMETRY, ATOMIC; VIBRIO;

ANIMALIA;

EID: 34249940516     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.05.025     Document Type: Article

References (34)

1. Gosal D., Ross O.A., and Toft M. Eur. J. Neurol. 13 (2006) 616
2. Chade A.R., Kasten M., and Tanner C.M. J. Neural Transm. Suppl. 70 (2006) 147
3. Riess O., Kruger R., Hochstrasser H., Soehn A.S., Nuber S., Franck T., and Berg D. J. Neural Transm. Suppl. 70 (2006) 181
4. Speciale S.G. Neurotoxicol. Teratol. 24 (2002) 607
5. Ross G.W., Abbott R.D., Petrovitch H., Morens D.M., Grandinetti A., Tung K.H., Tanner C.M., Masaki K.H., Blanchette P.L., Curb J.D., Popper J.S., and White L.R. JAMA 283 (2000) 2674
6. Ascherio A., Zhang S.M., Hernan M.A., Kawachi I., Colditz G.A., Speizer F.E., and Willett W.C. Ann. Neurol. 50 (2001) 56
7. Tan E.K., Tan C., Fook-Chong S.M., Lum S.Y., Chai A., Chung H., Shen H., Zhao Y., Teoh M.L., Yih Y., Pavanni R., Chandran V.R., and Wong M.C. J. Neurol. Sci. 216 (2003) 163
8. Chen J.F., Xu K., Petzer J.P., Staal R., Xu Y.H., Beilstein M., Sonsalla P.K., Castagnoli K., Castagnoli Jr. N., and Schwarzschild M.A. J. Neurosci. 21 (2001) RC143
9. Xu K., Xu Y.H., Chen J.F., and Schwarzschild M.A. Neurosci. Lett. 322 (2002) 13
10. Gevaerd M.S., Takahashi R.N., Silveira R., and Da Cunha C. Brain Res. Bull. 55 (2001) 101
11. Ross G.W., and Petrovitch H. Drugs Aging 18 (2001) 797
12. Shiozaki S., Ichikawa S., Nakamura J., Kitamura S., Yamada K., and Kuwana Y. Psychopharmacology 147 (1999) 90
13. Chen J.F., Steyn S., Staal R., Petzer J.P., Xu K., Van Der Schyf C.J., Castagnoli K., Sonsalla P.K., Castagnoli Jr. N., and Schwarzschild M.A. J. Biol. Chem. 277 (2002) 36040
14. Schwarzschild M.A., Xu K., Oztas E., Petzer J.P., Castagnoli K., Castagnoli Jr. N., and Chen J.F. Neurology 61 (2003) S55
15. Ulanowska K., Piosik J., Gwizdek-Wiśniewska A., and We{ogonek}grzyn G. Bioorg. Chem. 33 (2005) 402
16. Nicklas W.J., Youngster S.K., Kindt M.V., and Heikkila R.E. Life Sci. 40 (1987) 721
17. Trevor A.J., Castagnoli Jr. N., Caldera P., Ramsay R.R., and Singer T.P. Life Sci. 40 (1987) 713
18. Singer T.P., and Ramsay R.R. FEBS Lett. 274 (1990) 1
19. Kapuscinski J., and Kimmel M. Biophys. Chem. 35 (1993) 46
20. Zdunek M., Piosik J., and Kapuścinski J. Biophys. Chem. 84 (2000) 77
21. Piosik J., Ulanowska K., Gwizdek-Wisniewska A., Czyż A., Kapuścinski J., and We{ogonek}grzyn G. Mutat. Res. 530 (2003) 47
22. Piosik J., Gwizdek-Wisniewska A., Ulanowska K., Ochocinski J., Czyż A., and We{ogonek}grzyn G. Acta Biochim. Pol. 52 (2005) 923
23. Cashman J.R. Toxicology 43 (1987) 173
24. Yang S.C., Markey S.P., Bankiewicz K.S., London W.T., and Lunn G. Lab. Anim. Sci. 38 (1988) 563
25. Ulanowska K., and We{ogonek}grzyn G. J. Appl. Genet. 47 (2006) 85
26. Martel F., Keating E., Calhau C., and Azevedo I. Biochem. Pharmacol. 63 (2002) 1565
27. Monteiro R., Calhau C., Martel F., Faria A., Mateus N., and Azevedo I. Naunyn-Schmiedeberg's Arch. Pharmacol. 372 (2005) 147
28. Piosik J., Zdunek M., and Kapuscinski J. Biochem. Pharmacol. 63 (2002) 635
29. Weller K., Schutz H., and Petri I. Biophys. Chem. 19 (1984) 289
30. Czyż A., Jasiecki J., Bogdan A., Szpilewska H., and We{ogonek}grzyn G. Appl. Environ. Microbiol. 66 (2000) 599
31. We{ogonek}grzyn G., and Czyż A. J. Appl. Microbiol. 95 (2003) 1175
32. Czyż A., Szpilewska H., Dutkiewicz R., Kowalska W., Biniewska-Godlewska A., and We{ogonek}grzyn G. Mutat. Res. 519 (2002) 67
33. Podgórska B., Che{ogonek}ć E., Ulanowska K., and We{ogonek}grzyn G. J. Appl. Genet. 46 (2005) 241
34. Klein G., Walczak R., Krasnowska E., Blaszczak A., and Lipinska B. Mol. Microbiol. 16 (1995) 801